Page last updated: 2024-12-05

alpha-hydroxy-gamma-methylmercaptobutyric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-hydroxy-gamma-methylmercaptobutyric acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11427
CHEMBL ID2104213
CHEBI ID137228
SCHEMBL ID167046
MeSH IDM0052206

Synonyms (57)

Synonym
z94465h1y7 ,
2-hydroxy-4-(methylthio) butanoic acid
unii-z94465h1y7
butyric acid, 2-hydroxy-4-(methylthio)-
butanoic acid, 2-hydroxy-4-(methylthio)-
alpha-hydroxy-gamma-(methylthio)butyric acid
alimet
2-hydroxy-4-(methylthio)butanoic acid
mha-fa
hsdb 5700
dl-2-hydroxy-4-methylthiobuttersaeure
(+-)-2-hydroxy-4-(methylthio)butyric acid
alpha-hydroxy-gamma-methylmercaptobutyric acid
2-hydroxy-4-(methylthio)butyric acid
gamma-(methylthio)-alpha-hydroxybutyric acid
alpha-hydroxy-gamma-(methylmercapto)butyric acid
mha acid
(rs)-3-hydroxy-4-(methylthio)buttersaeure
desmeninol [inn]
einecs 209-523-0
CHEBI:137228
desmeninol
2-hydroxy-4-methylsulfanylbutanoic acid
583-91-5
H0654
2-hydroxy-4-methylthiobutanoic acid
CHEMBL2104213
FT-0612550
AKOS009157403
dl-2-hydroxy-4-methylthio-butanoic acid
2-hydroxy-4-methylthio-butanoic acid, (+/-)-
(+/-)-2-hydroxy-4-(methylthio)butyric acid
desmeninol [who-dd]
desmeninol [hsdb]
ONFOSYPQQXJWGS-UHFFFAOYSA-N
2-hydroxy-4-(methylthio)-butanoic acid
2-hydroxy-4-(methylsulfanyl)butanoic acid
SCHEMBL167046
W-105391
2-hydroxy-4-(methylthio)butyricacid
LMFA01050480
dl-2-hydroxy-4-(methylthio)butyric acid
mfcd00070490
SR-01000944858-1
sr-01000944858
H11809
(+/-)-2-hydroxy-4-(methylthio)butanoic acid
2-hydroxy-4-(methylthio)-butyric acid
4857-44-7 (calcium[2:1] salt)
FT-0699945
DTXSID50862236
EN300-103144
Q27295171
A869459
4-methylsulfanyl-2-oxidanyl-butanoic acid
Z788000926
2-hydroxy-4-(methylthio)butyric acid, tech grade

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Dietary ethoxyquin (EQ) and methionine hydroxy analog (MHA) protected 6-8-month-old wethers from toxic doses of bitterweed (Hymenoxys odorata DC."( Elimination of adverse effects of ethoxyquin (EQ) by methionine hydroxy analog (MHA). Protective effects of EQ and MHA for bitterweed poisoning in sheep.
Anderson, AC; Calhoun, MC; Herrig, BW; Jones, LP; Kim, HL, 1983
)
0.27

Bioavailability

ExcerptReferenceRelevance
" In a second experiment procedures were developed for a bioavailability assessment by comparing the growth responses to CI and intraperitoneal-injected (IP) DL-MET or DL-HMA in chicks fed a crystalline-amino-acid diet deficient in methionine."( Absorption and bioavailability of DL-methionine hydroxy analog compared to DL-methionine.
Baker, DH; Castanon, F; Han, YM; Parsons, CM, 1990
)
0.28
" When 14C-HMB was delivered directly into the hindgut, the rate of absorption from this gastrointestinal site was about 40% of the administered dose per hour."( Absorption of 14C-2-hydroxy-4-(methylthio)butanoic acid (Alimet) from the hindgut of the broiler chick.
Dibner, JJ; Ivey, FJ; Knight, CD; Swick, RA, 1988
)
0.27
"An experiment was conducted using molted hens to estimate the bioavailability of DL-methionine hydroxy analogue-free acid (MHA-FA) relative to DL-methionine (DLM)."( Estimation of bioavailability of DL-methionine hydroxy analogue relative to DL-methionine in layers with exponential and slope-ratio models.
Abebe, A; Bateman, A; Bryant, M; Liu, Z; Roland, D, 2004
)
0.32
" In conclusion, these data indicate that the use of MHA chelates could be a valuable tool to increase bioavailability of trace minerals and reduce the environmental impact of animal manure."( Metal chelates of 2-hydroxy-4-methylthiobutanoic acid in animal feeding. Part 2: Further characterizations, in vitro and in vivo investigations.
Biagi, G; Cinti, E; Elviri, L; Ferruzza, S; Leonardi, G; Predieri, G; Tegoni, M; Zagnoni, I, 2005
)
0.33
"05% using a calibration curve established by modeling the area under the curve response to increasing doses of Met supplied as Smartamine M, whose bioavailability (80%) is considered the reference value."( Methionine availability in plasma of dairy cows supplemented with methionine hydroxy analog isopropyl ester.
Graulet, B; Richard, C; Robert, JC, 2005
)
0.33
" 1 showed that the average relative bioavailability of MHA-Ca to dl-Met to support N retention (% of N intake) was 71% on a product- to-product basis (85% on an equimolar basis)."( Bioavailability of methionine hydroxy analog-calcium salt relative to DL-methionine to support nitrogen retention and growth in starter pigs.
Dapoza, C; Htoo, JK; Nyachoti, CM; Opapeju, FO, 2012
)
0.38
"Experiments were conducted to determine the relative bioavailability (RBV) of the calcium salt of the hydroxy analog of dl-methionine (MHA-Ca, 84%) to dl-methionine (dl-Met, 99%) as Met sources fed to pigs."( Bioavailability of the calcium salt of dl-methionine hydroxy analog compared with dl-methionine for nitrogen retention and the preference of nursery pigs for diets based on the 2 forms of methionine.
Htoo, JK; Huyen, TT; Kinh, V; Lee, JW; Lindemann, MD; Ramos, SH; Wang, MQ, 2020
)
0.56
"Two nitrogen balance studies were conducted to evaluate the relative bioavailability values (RBV) of dl-methionine (dl-Met) and dl-methionine hydroxy analog calcium salt (MHA-Ca) to l-methionine (l-Met) as Met sources fed to pigs."( Bioavailability of the dl-methionine and the calcium salt of dl-methionine hydroxy analog compared with l-methionine for nitrogen retention in starter pigs.
Chen, D; Gao, J; Htoo, JK; Shu, Y; Wang, H; Yu, B; Yuan, Z; Zhou, H, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" When birds were dosed with radiolabelled HMB and tissue samples were tested, results showed that the 14C-HMB that was absorbed from the hindgut was incorporated into protein in a dose-related manner."( Absorption of 14C-2-hydroxy-4-(methylthio)butanoic acid (Alimet) from the hindgut of the broiler chick.
Dibner, JJ; Ivey, FJ; Knight, CD; Swick, RA, 1988
)
0.27
" Derivatization of L-methionine generally lowered potency, calculated as the ratio of the slopes of the two dose-response curves."( Nutritional value and safety of methionine derivatives, isomeric dipeptides and hydroxy analogs in mice.
Friedman, M; Gumbmann, MR, 1988
)
0.27
" It was concluded that LMET was the major methionine analogue excreted from roosters dosed with either HMB-FA or LMET, and that HMB-FA was not excreted by the avian kidney."( Studies of the renal excretion of the hydroxyl analogue of methionine by the chick.
Combs, GF; Saroka, JM, 1986
)
0.27
" Calcium-induced kidney damage was attenuated in a dose-response fashion by supplementing the HC diet with liquid methionine hydroxy analog and DL-methionine."( Liquid methionine hydroxy analog (free acid) and DL-methionine attenuate calcium-induced kidney damage in domestic fowl.
Ford, BC; Leach, RM; Robey, WW; Wideman, RF; Wise, DF, 1993
)
0.29
" Duodenal samples were collected at 16, 20, and 24 h after dosing for the last 5 d and pooled."( Ruminal escape, gastrointestinal absorption, and response of serum methionine to supplementation of liquid methionine hydroxy analog in dairy cows.
Knight, CD; Koenig, KM; McCullough, PR; Rode, LM, 1999
)
0.3
" Serum methionine concentration peaked at 3 and 6 h after dosing and increased in proportion to the amount of the analog administered."( Rumen degradation and availability of various amounts of liquid methionine hydroxy analog in lactating dairy cows.
Knight, CD; Koenig, KM; Rode, LM; Vázquez-Añón, M, 2002
)
0.31
" When the 4 trials were combined, the dose-response curve with the best goodness of fit was linear for HMTBA and quadratic for DLM."( Evidence for 2-hydroxy-4(methylthio) butanoic acid and DL-methionine having different dose responses in growing broilers.
Firman, J; González-Esquerra, R; Hampton, T; Knight, CD; Ritcher, S; Saleh, E; Vázquez-Añón, M, 2006
)
0.33
"HMTBA restored oxidative redox status under OS conditions and its antioxidant properties were positively correlated with the dosage included in diet."( Comparative in vivo antioxidant capacity of DL-2-hydroxy-4-methylthiobutanoic acid (HMTBA) and DL-methionine in male mice fed a high-fat diet.
Le, G; Shi, Y; Tang, X; Yang, Y, 2011
)
0.37
", at natural abundance of (13)C) but simultaneously dosed with equivalent dosages of [1-(13)C]-l-Met."( Assessing the ruminal action of the isopropyl ester of 2-hydroxy-4-(methylthio) butanoic acid in continuous and batch cultures of mixed ruminal microbes.
Bequette, BJ; Devillard, E; Firkins, JL; Fowler, CM; Plank, JE, 2015
)
0.42
"048% Met (Met + HMBi)-were dosed every 8h simultaneously with 3-times-daily feeding into continuous cultures."( Kinetics of microbial methionine metabolism in continuous cultures administered different methionine sources.
Bequette, BJ; Devillard, E; Firkins, JL; Fowler, CM, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thia fatty acidAny fatty acid having at least one of the chain methylene groups replaced by sulfur. Members of this group are believed to have important pharmacological (antioxidant and antiatherosclerosis) properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1130306Inhibition of glycolic acid oxidase (unknown origin) assessed as enzyme-mediated reduction of NaDCIP by sodium glycolate after 1 to 3 mins by spectrophotometer analysis1979Journal of medicinal chemistry, Jun, Volume: 22, Issue:6
Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (167)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (23.95)18.7374
1990's23 (13.77)18.2507
2000's49 (29.34)29.6817
2010's47 (28.14)24.3611
2020's8 (4.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.41 (24.57)
Research Supply Index5.22 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials14 (8.24%)5.53%
Reviews3 (1.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other153 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]